AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

A Study of Auricular Neurostimulation for Children With Cyclic Vomiting Syndrome

RecruitingNAAges 5 Years - 18 YearsAllMedical College of Wisconsin
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Cyclic vomiting syndrome (CVS) is a fairly common disorder characterized by relentless episodes of vomiting followed by return to baseline health.The majority of children with CVS have concurrent severe abdominal pain and migraine-features, causing significant disability during the attacks. There are very few non-drug treatment options for CVS. Many patients are treated with antidepressants that are often ineffective and may cause serious side effects. Emergency room visits and hospitalizations for patients with CVS is extremely high and the syndrome has an immense impact on quality of life. Safe and effective, non-pharmacological therapies for children with CVS are greatly needed. Nausea, vomiting and gastrointestinal pain is modulated by the vagus nerve, an important regulator of the autonomic nervous system. The vagus communicates signals between the gastrointestinal tract and the ce

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Episodic vomiting that meet criteria for CVS based on the 2025 NASPGHAN guidelines for diagnosis of pediatric CVS * English-speaking * Lack of other explanation for vomiting * Intact external ear that is free of infection or severe dermatological conditions * Stable stable vital signs for their respective age * No currently implanted electrical device * Family able to accurately describe symptoms and number of vomiting episodes * At least 2 vomiting episodes during the 6 months prior to enrollment Exclusion Criteria: * Medically complex children or those who take a medication or suffer from another active disease that explain symptoms * Children or their parents who have significant developmental delay * Participants diagnosed with alternate conditions that explains their symptoms after undergoing medical workup per standard of care * Patients with findings of active disease such as intestinal malrotation, peptic ulcer disease, H.pylori gastritis, celiac disease, inflammatory bowel disease, allergic disorders, hydronephrosis, metabolic disorder or any other active chronic condition or medication that may cause of vomiting * Patients who are treated with a new drug affecting the central nervous system in the 4 weeks prior to enrollment * Pregnancy * Severe cardiopulmonary diseases such as chronic obstructive pulmonary disease (COPD) or coronary artery disease * Current chronic marijuana use defined as marijuana use \> 2 times per week over the last 6 months prior to study enrollment * Previously treated with a PENFS device
๐Ÿ’Š

What it tests

  • Active percutaneous electrical nerve field stimulation
  • Sham percutaneous electrical nerve field stimulation
๐Ÿ“

Where

1 site
Children's Wisconsin
Milwaukee, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy